LDL cholesterol counteracts the antitumour effect of tyrosine kinase inhibitors against renal cell carcinoma.

MLA

Naito, Sei, et al. “LDL Cholesterol Counteracts the Antitumour Effect of Tyrosine Kinase Inhibitors against Renal Cell Carcinoma.” British Journal of Cancer, vol. 116, no. 9, Apr. 2017, pp. 1203–07. EBSCOhost, https://doi.org/10.1038/bjc.2017.77.

APA

Naito, S., Makhov, P., Astsaturov, I., Golovine, K., Tulin, A., Kutikov, A., Uzzo, R. G., & Kolenko, V. M. (2017). LDL cholesterol counteracts the antitumour effect of tyrosine kinase inhibitors against renal cell carcinoma. British Journal of Cancer, 116(9), 1203–1207. https://doi.org/10.1038/bjc.2017.77

Chicago

Naito, Sei, Peter Makhov, Igor Astsaturov, Konstantin Golovine, Alexei Tulin, Alexander Kutikov, Robert G Uzzo, and Vladimir M Kolenko. 2017. “LDL Cholesterol Counteracts the Antitumour Effect of Tyrosine Kinase Inhibitors against Renal Cell Carcinoma.” British Journal of Cancer 116 (9): 1203–7. doi:10.1038/bjc.2017.77.